Michael G. Erickson - 13 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael G. Erickson
Issuer symbol
IDXX
Transactions as of
13 Feb 2025
Net transactions value
-$78,682
Form type
4
Filing time
18 Feb 2025, 21:42:49 UTC
Previous filing
12 Feb 2025
Next filing
14 Aug 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +69 +0.33% $0.000000 20,905 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +93 +0.44% $0.000000 20,998 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +94 +0.45% $0.000000 21,092 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +301 +1.4% $0.000000 21,393 14 Feb 2025 Direct
transaction IDXX Common Stock Tax liability $78,682 -177 -0.83% $444.53 21,216 14 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +6,320 $0.000000 6,320 13 Feb 2025 Common Stock 6,320 $459.76 Direct F1
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.000000 217 13 Feb 2025 Common Stock 217 $459.76 Direct F2
transaction IDXX Restricted Stock Unit Award $0 +734 $0.000000 734 13 Feb 2025 Common Stock 734 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +734 $0.000000 734 13 Feb 2025 Common Stock 734 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -69 -100% $0.000000 0 14 Feb 2025 Common Stock 69 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -93 -50% $0.000000 92 14 Feb 2025 Common Stock 93 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -94 -33% $0.000000 188 14 Feb 2025 Common Stock 94 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -301 -25% $0.000000 903 14 Feb 2025 Common Stock 301 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F3 Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2022.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2024.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2025.